Showing results (141-150 of 177) with videos related to

Sort By:
Pageof 18
Journal of Virology|November 25, 2005
Genetic and stochastic influences on the interaction of human immunodeficiency virus type 1 and cytotoxic T lymphocytes in identical twinsOtto O Yang, Joseph Church, Christina M R Kitchen, et al.
Bioconjugate Chemistry|July 3, 2019
Human Vault Nanoparticle Targeted Delivery of Antiretroviral Drugs to Inhibit Human Immunodeficiency Virus Type 1 InfectionJennifer A Fulcher, Kyle Tamshen, Alexander L Wollenberg, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2005
Effects of HIV-1 infection on lymphocyte phenotypes in blood versus lymph nodesOtto O Yang, John J Ferbas, Mary Ann Hausner, et al.
Msphere|July 7, 2021
Longitudinal COVID-19 Surveillance and Characterization in the Workplace with Public Health and Diagnostic EndpointsManjula Gunawardana, Jessica Breslin, John M Cortez, et al.
Plos One|February 22, 2014
Differential blood and mucosal immune responses against an HIV-1 vaccine administered via inguinal or deltoid injectionOtto O Yang, F Javier Ibarrondo, Charles Price, et al.
Nature Nanotechnology|February 19, 2013
Biomimetic enzyme nanocomplexes and their use as antidotes and preventive measures for alcohol intoxicationYang Liu, Juanjuan Du, Ming Yan, et al.
Plos One|October 30, 2013
Natural killer T cells in advanced melanoma patients treated with tremelimumabF Javier Ibarrondo, Otto O Yang, Thinle Chodon, et al.
Vaccine|March 21, 2006
Transience of vaccine-induced HIV-1-specific CTL and definition of vaccine "response"Beth D Jamieson, F Javier Ibarrondo, Johnson T Wong, et al.
Frontiers in Immunology|March 2, 2023
Persistent memory despite rapid contraction of circulating T Cell responses to SARS-CoV-2 mRNA vaccinationEllie Taus, Christian Hofmann, F Javier Ibarrondo, et al.
Pageof 18